Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature

被引:402
作者
Klinkert, P
Post, PN
Breslau, PJ
van Bocke, JH
机构
[1] Red Cross Hosp, Dept Surg, NL-2506 The Hague, Netherlands
[2] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
关键词
review; vascular; vascular patency; saphenous vein; polytetrafluoroethylene; blood vessel prosthesis;
D O I
10.1016/j.ejvs.2003.12.027
中图分类号
R61 [外科手术学];
学科分类号
摘要
The autogenous saphenous vein is considered the best bypass graft material for arterial bypasses below the inguinal ligament. However, a synthetic graft or prosthesis is considered an acceptable alternative, especially when the distal anastomosis is situated above the knee. Some studies even suggest that patency rates for vein and synthetic grafts are comparable, whereas others indicate that a vein graft is superior to a prosthetic graft, even above the knee. To test the hypothesis that both vein grafts and synthetic prostheses are equally beneficial in the above-knee position, we performed a systematic review of available studies comparing the potency of saphenous vein and polytetrafluoroethylene (PTFE) as bypass material. English and German medical literature from 1966 to 2002 was searched using Medline, and 25 articles meeting our inclusion and exclusion criteria were selected. The patency of venous bypasses was superior to that of PTFE bypasses at all time intervals studied. After 2 years, the primary patency rate of venous bypasses was 81% as compared to 67% for PTFE bypasses, and after 5 years it was 69 and 49%. respectively. After 5 years, the secondary patency of PTFE bypasses reached 60%,. When only randomized trials were considered, venous bypasses were again superior to PTFE bypasses at all intervals studied. After 2 years, the primary patency rate of venous and PTFE bypasses was 80 and 69%, respectively, and after 5 years it was 74 and 39%, respectively. Since both randomized and retrospective studies comparing venous with PTFE bypasses showed that vein grafts were 'better' than PTFE prostheses, the null hypothesis that there is no difference between the two types of graft material was rejected (p = 0.008). We conclude from this systematic review that if a saphenous vein is available, a venous bypass should be chosen at all times, even if patients have an anticipated short life expectancy (< 2 years). If the saphenous vein is absent or not suitable for bypass grafting, PTFE is a good alternative as bypass material.
引用
收藏
页码:357 / 362
页数:6
相关论文
共 37 条
[1]  
AALDERS GJ, 1992, J VASC SURG, V16, P816
[2]   Prosthetic above-knee femoropopliteal bypass grafting: Results of a multicenter randomized prospective trial [J].
Abbott, WM ;
Green, RM ;
Matsumoto, T ;
Wheeler, JR ;
Miller, N ;
Veith, FJ ;
Suggs, WD ;
Hollier, L ;
Money, S ;
Garrett, HE ;
Moore, WS ;
Dean, RH ;
Cronenwett, JL ;
Carter, S ;
Greenhalgh, RM ;
ODonnell, TF .
JOURNAL OF VASCULAR SURGERY, 1997, 25 (01) :19-28
[3]   Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses [J].
AbuRahma, AF ;
Robinson, PA ;
Holt, SM .
SURGERY, 1999, 126 (04) :594-601
[4]  
Achermann A, 1998, Swiss Surg, V4, P129
[5]   Femoropopliteal bypass for claudication: Vein vs PTFE [J].
Allen, BT ;
Reilly, JM ;
Rubin, BG ;
Thompson, RW ;
Anderson, CB ;
Flye, MW ;
Sicard, GA .
ANNALS OF VASCULAR SURGERY, 1996, 10 (02) :178-185
[6]  
Archie J P Jr, 1994, Ann Vasc Surg, V8, P475, DOI 10.1007/BF02133068
[7]  
BERGAN JJ, 1982, SURGERY, V92, P921
[8]  
BERLAKOVICH GA, 1994, ARCH SURG-CHICAGO, V129, P297
[9]  
Buchbinder D, 1989, Ann Vasc Surg, V3, P210, DOI 10.1016/S0890-5096(07)60025-9
[10]   A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting [J].
Burger, DHC ;
Kappetein, AP ;
van Bockel, JH ;
Breslau, PJ .
JOURNAL OF VASCULAR SURGERY, 2000, 32 (02) :278-283